Coprelotamab (Anti-ERBB2 / HER2 / CD340)
Coprelotamab (Anti-ERBB2 / HER2 / CD340) (A2810-GRP)
Products
Description
Coprelotamab (Anti-ERBB2 / HER2 / CD340) is humanized monoclonal antibody targated against HER2 with the potential to treat breast cancer. MW : 145.36 KD.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | A2810 |
| Target | EGFR |